Indonesia: Food and Drugs Law

Indonesia’s Constitutional Court (Mahkamah Konstitusi) has reinstated a key provision limiting pharmaceutical patent protection, signaling a renewed commitment to balancing patent rights with public access to medicines. In its ruling to Case No. 255/PUU-XXIII/2025, the court partially granted a petition for judicial review of Law No. 65 of 2024, which had amended the country’s Patent Law, and ordered the restoration of a provision that had excluded certain pharmaceutical inventions from patentability.

Indonesia’s halal product assurance initiatives have undergone a significant development following the enactment of Government Regulation No. 42 of 2024 on Implementation of the Halal Product Assurance (“GR 42/2024”).

Indonesia's National Agency of Drug and Food Control has introduced comprehensive changes to nutritional labeling requirements for processed foods, including the implementation of a color-coded Nutri-Level system for beverages, updated nutrient reference values, and revised serving-size standards. Food and beverage manufacturers, importers, and distributors have until June 2028 to comply with these new requirements. How will these regulatory changes impact businesses operating in Indonesia's food and bevera

Law No. 33 of 2014 regarding Halal Product Guarantees, as amended by Law No. 6 of 2023 on the stipulation of Government Regulation in Lieu of Law No. 2 of 2022...

Data exclusivity is generally understood to mean generic drug makers may not rely on data submitted by the originator to obtain approval for the same drug.

Enacted in 2009, Indonesia's current Law on Health (Law No. 36/2009) is due for a refresh. The government realized that the law has not maintained its relevance when it comes to health trends...

This article is the first in CNPUpdate's new Indonesia Investment Updates series and aims to provide you with a general overview and the laws and regulations governing foreign investments into Indonesia.

Indonesian National Police arrested the director of pharmaceutical company PT Jasa Karunia Investindo (JKI)

Indonesia's problem of trademark piracy has reared its head again. This time, DC Comics lost a recovation case against Marxing Fam Makmur‘s SUPERMAN trademark.